Quality ManagementAMH Health, LLC | Medicare AdvantageJune 5, 2024

Glycemic Status Assessment for Patients With Diabetes (GSD)

HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These measures are used to drive improvement efforts surrounding best practices.

The Glycemic Status Assessment for Patients With Diabetes measure looks at the percentage of members 18 to 75 years of age with diabetes (types 1 and 2) whose most recent glycemic status (hemoglobin A1c [HbA1c] or glucose management indicator [GMI]) was at the following levels during the measurement year:

  • Glycemic status < 8%
  • Glycemic status > 9%

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Plans offered by AMH Health, LLC., a joint venture between MaineHealth and Anthem Partnership Holding Company, LLC. AMH Health is an independent licensee of the Blue Cross Blue Shield Association.

MEAMH-CR-046300-23-CPN45779, MEAMH-CR-061061-24-SRS60940

ATTACHMENTS: Glycemic Status Assessment for Patients With Diabetes (GSD) (pdf - 1.3mb)